How COVID-19 is Transforming Smilow Cancer Hospital for the Future
When COVID-19 surged in the spring of 2020, the physicians and staff who work in ambulatory care at Smilow Cancer Hospital and the Smilow Cancer Hospital Network were forced to respond with lightning speed, creating temporary spaces that would allow for social distancing, beefing up technology for relatively novel telehealth visits, and rethinking patient care to keep everyone safe.
Rallying Resources Around DNA Repair Research
When it comes to unlocking the secrets of DNA repair, Yale Cancer Center has an armamentarium at work. In the last two years, Yale’s team has made significant advances in targeting the BRCA-dependent DNA repair axis for cancer therapy and determined that both BRCA1 and BRCA2 protein are involved in DNA repair, but they have fundamentally different mechanisms.
Adapting to the Changing Liver Cancer Landscape
In recent years, the liver cancer landscape has been rapidly changing in the United States. Skyrocketing hepatitis C cases and the emergence of a worrying new at-risk group for hepatitis C are presenting Yale Cancer Center researchers and clinicians with new challenges and opportunities in their approach to patient outreach and treatment for liver cancer.
Mining Brain Metastasis for Answers
When lung cancer and breast cancer relapse, they often metastasize in the brain. The tumors that arise in the brain develop novel characteristics, differences that oft en confer resistance to existing drug therapies and create opportunities for new detection and treatment approaches for Yale Cancer Center researchers.
Paving the way for Cancer Health Equity
Since the appointment of Marcella Nunez-Smith, MD, MHS, as Director of the newly formed Center for Community Engagement and Health Equity (CEHE) within Smilow Cancer Hospital and Yale Cancer Center, the mission of ensuring cancer health equity and improving outcomes with an emphasis on traditionally marginalized communities, has begun to take shape.
A Pressing Need for New Ideas for Pancreatic Cancer
Despite poor outcomes nationally and internationally, patients do better when they receive treatment at facilities like Smilow Cancer Hospital. Our unique ability to bring together clinicians and scientists focused on pancreatic cancer is propelling research advances and bringing renewed hope to patients.
Taking a Dumbbell to Drug-Resistant Cancers
The hope is that PROTACs can treat other “undruggable” cancers that don’t respond to current treatments, including types of lung, breast, and colorectal cancers that may not have an active site on which a small-molecule drug or monoclonal antibody could bind.
Comprehensive Breast Cancer Care at the Smilow Cancer Hospital Care Centers in Trumbull, Fairfield, and at Bridgeport Hospital
Smilow Cancer Hospital, in partnership with the Norma Pfriem Breast Center in Trumbull, Fairfield, and at Bridgeport Hospital, are at the forefront of providing innovative and compassionate multi- disciplinary breast care.
Maryam Lustberg Named Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center
Maryam Lustberg, MD, MPH, has been appointed Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center.